NO142441C - Analogifremgangsmaate ved fremstilling av terapeutisk virksomme karboksylsyrederivater - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk virksomme karboksylsyrederivater

Info

Publication number
NO142441C
NO142441C NO740137A NO740137A NO142441C NO 142441 C NO142441 C NO 142441C NO 740137 A NO740137 A NO 740137A NO 740137 A NO740137 A NO 740137A NO 142441 C NO142441 C NO 142441C
Authority
NO
Norway
Prior art keywords
preparation
carboxylic acid
therapeutically effective
acid derivatives
analogy procedure
Prior art date
Application number
NO740137A
Other languages
English (en)
Norwegian (no)
Other versions
NO142441B (no
NO740137L (no
Inventor
Kozaburo Harita
Yukiyoshi Ajisawa
Kinji Iizuka
Yukihiko Kinoshita
Tetsuhide Kamijo
Michihiro Kobayashi
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of NO740137L publication Critical patent/NO740137L/no
Publication of NO142441B publication Critical patent/NO142441B/no
Publication of NO142441C publication Critical patent/NO142441C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO740137A 1973-01-18 1974-01-17 Analogifremgangsmaate ved fremstilling av terapeutisk virksomme karboksylsyrederivater NO142441C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP735973A JPS5640710B2 (es) 1973-01-18 1973-01-18

Publications (3)

Publication Number Publication Date
NO740137L NO740137L (no) 1974-07-19
NO142441B NO142441B (no) 1980-05-12
NO142441C true NO142441C (no) 1980-08-20

Family

ID=11663750

Family Applications (1)

Application Number Title Priority Date Filing Date
NO740137A NO142441C (no) 1973-01-18 1974-01-17 Analogifremgangsmaate ved fremstilling av terapeutisk virksomme karboksylsyrederivater

Country Status (18)

Country Link
US (2) US3940422A (es)
JP (1) JPS5640710B2 (es)
AT (1) AT333726B (es)
BE (1) BE809935A (es)
BG (1) BG24538A3 (es)
CH (2) CH613442A5 (es)
DE (1) DE2402398C3 (es)
DK (1) DK139676C (es)
ES (1) ES422395A1 (es)
FI (1) FI60555C (es)
FR (1) FR2214476B1 (es)
GB (1) GB1446141A (es)
HU (1) HU168055B (es)
IT (1) IT1054151B (es)
NL (1) NL179370C (es)
NO (1) NO142441C (es)
SE (1) SE411117B (es)
SU (1) SU520041A3 (es)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144250A (en) * 1973-05-14 1979-03-13 Stauffer Chemical Company Herbicidal active carboxanilide derivatives
JPS5830302B2 (ja) * 1974-04-16 1983-06-28 キツセイヤクヒンコウギヨウ カブシキガイシヤ シンキホウコウゾクカルボンサンアミドユウドウタイ ノ セイゾウホウホウ
GB1484413A (en) * 1974-04-18 1977-09-01 Kissei Pharmaceutical Aromatic amidocarboxylic acid derivatives
DE2629752A1 (de) * 1976-07-02 1978-01-05 Boehringer Mannheim Gmbh Neue carbonsaeurederivate und verfahren zu ihrer herstellung
JPS56135454A (en) * 1980-03-26 1981-10-22 Kissei Pharmaceut Co Ltd Preparation of aromatic carboxylic acid amide derivative
US4337270A (en) * 1980-05-21 1982-06-29 Hisamitsu Pharmaceutical Co., Inc. Novel anthranilic acid derivatives
JPS5838244A (ja) * 1981-09-01 1983-03-05 Kissei Pharmaceut Co Ltd 核置換シンナモイルアントラニル酸塩およびその製造方法
US4536346A (en) * 1983-05-06 1985-08-20 American Cyanamid Company Aralkanamidophenyl compounds
JPS6097946A (ja) * 1983-11-01 1985-05-31 Ono Pharmaceut Co Ltd カルボキサミド誘導体
JPS60116657A (ja) * 1983-11-30 1985-06-24 Ono Pharmaceut Co Ltd アニリン誘導体
JPS60142936A (ja) * 1983-12-28 1985-07-29 Ono Pharmaceut Co Ltd 置換フエニル誘導体
JPS60146856A (ja) * 1983-12-30 1985-08-02 Kissei Pharmaceut Co Ltd α−ハロ芳香族アミドカルボン酸誘導体及びこの化合物より成る抗アレルギ−剤
JPS60146857A (ja) * 1983-12-30 1985-08-02 Kissei Pharmaceut Co Ltd α−ハロ芳香族アミドカルボン酸誘導体及びこの化合物より成る抗アレルギ−剤
IT1196348B (it) * 1984-11-29 1988-11-16 Italfarmaco Spa Composti ad attivita'antiinfiammatoria
JPH078851B2 (ja) * 1985-07-29 1995-02-01 鐘淵化学工業株式会社 ３−フエニルチオメチルスチレン誘導体
JPH0733357B2 (ja) * 1986-09-30 1995-04-12 日本レダリ−株式会社 ケイ皮酸誘導体
JPH0692353B2 (ja) * 1987-05-26 1994-11-16 マルコ製薬株式会社 新規なアミノ安息香酸アミド誘導体およびその製造法
JP2632732B2 (ja) * 1989-11-06 1997-07-23 株式会社興人 Ｎ―（３’，４’―ジメトキシシンナモイル）アントラニル酸の製造方法
US6515009B1 (en) * 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) * 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
JP2617407B2 (ja) * 1992-09-14 1997-06-04 キッセイ薬品工業株式会社 血管内膜細胞過剰増殖疾患の予防および治療剤
US6306421B1 (en) 1992-09-25 2001-10-23 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5770609A (en) * 1993-01-28 1998-06-23 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6395494B1 (en) 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6663881B2 (en) 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5595722A (en) * 1993-01-28 1997-01-21 Neorx Corporation Method for identifying an agent which increases TGF-beta levels
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
JPH08510451A (ja) * 1993-05-13 1996-11-05 ネオルックス コーポレイション 異常増殖性平滑筋細胞に関連した病因の予防及び治療
US20030083733A1 (en) * 1997-10-10 2003-05-01 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US20020091433A1 (en) * 1995-04-19 2002-07-11 Ni Ding Drug release coated stent
US5837313A (en) * 1995-04-19 1998-11-17 Schneider (Usa) Inc Drug release stent coating process
US6099562A (en) * 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
AU6277396A (en) * 1995-06-07 1996-12-30 Neorx Corporation Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
AU1618697A (en) * 1996-02-06 1997-08-28 Japan Tobacco Inc. Novel compounds and pharmaceutical use thereof
US6019104A (en) * 1996-12-30 2000-02-01 Kissei Pharmaceutical Co., Ltd. Method for the treatment or prevention of restenosis associated with coronary intervention
DE19935219A1 (de) 1999-07-27 2001-02-01 Boehringer Ingelheim Pharma Carbonsäureamide, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung
DE10065043A1 (de) * 2000-12-23 2002-07-04 Boehringer Ingelheim Pharma Carbonsäureamide, diese Verbindungen enthaltene Arzneimittel, deren Verwendung und Herstellung
DE10065042A1 (de) * 2000-12-23 2002-06-27 Boehringer Ingelheim Pharma Carbonsäureamide, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung
US6613083B2 (en) * 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
EP1318141A1 (en) * 2001-12-04 2003-06-11 Dsm Nv Process for treating an aqueous medium containing phosphate, cyclohexanone and cyclohexanone oxime
JP4138659B2 (ja) * 2001-12-04 2008-08-27 ディーエスエム アイピー アセッツ ビー．ブイ． シクロヘキサノンオキシムおよびシクロヘキサノンを含む水性媒体を処理する方法
MXPA04005427A (es) * 2001-12-10 2005-04-19 Amgen Inc Ligandos de receptor vainilloide y su uso en tratamientos.
US7482488B2 (en) * 2002-08-29 2009-01-27 Temple University - Of The Commonwealth System Of Higher Education Aryl and heteroaryl propene amides, derivatives thereof and therapeutic uses thereof
DE10254872A1 (de) 2002-11-25 2004-06-03 Symrise Gmbh & Co. Kg Anthranilsäureamide und deren Derivate als kosmetische und pharmazeutische Wirkstoffe
WO2005110392A1 (en) * 2004-05-14 2005-11-24 The University Of Melbourne Methods of modulating flt3 activity
CA2594460A1 (en) 2005-01-14 2006-07-20 The Board Of Trustees Of The Leland Stanford Junior University A method of modulating t cell functioning
ITMI20050261A1 (it) * 2005-02-21 2006-08-22 Carlo Ghisalberti Analoghi strutturali di avenatramidi loro uso in composizioni utili nel trattamento di disordini dermatologici
EP1886662B1 (de) * 2006-06-14 2014-04-09 Symrise AG Antimikrobiell wirksame Verbindungen zur Behandlung von Mundgeruch
ES2462925T3 (es) * 2006-06-14 2014-05-26 Symrise Ag Compuestos con efecto antimicrobiano para el tratamiento de fetidez oral
MX352516B (es) * 2006-07-05 2017-04-06 Fibrotech Therapeutics Pty Ltd Compuestos terapeuticos.
WO2008131481A1 (en) * 2007-04-26 2008-11-06 Fibrotech Therapeutics Pty Ltd Treatment of mesangioproliferative diseases
EP2220028B1 (en) * 2007-12-21 2016-03-09 Fibrotech Therapeutics PTY LTD Halogenated analogues of anti-fibrotic agents
WO2010071865A1 (en) 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
WO2010071866A2 (en) 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Combination therapy for arthritis with tranilast
US20100160351A1 (en) * 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
EP2455077B1 (en) 2009-06-17 2014-06-11 National University Corporation Kumamoto University Prophylactic and/or therapeutic agent for dysmenorrhea
JP5904944B2 (ja) 2009-10-22 2016-04-20 フィブロテック セラピューティクス プロプライエタリー リミテッド 縮合環類似体の抗線維症剤
DE102009046115A1 (de) * 2009-10-28 2011-09-08 Bayer Schering Pharma Aktiengesellschaft Substituierte 3-Phenylpropansäuren und ihre Verwendung
KR101554078B1 (ko) * 2011-01-25 2015-09-17 미쓰이가가쿠 아그로 가부시키가이샤 방향족 아미드카르본산 유도체의 제조방법
WO2014186737A1 (en) * 2013-05-16 2014-11-20 The Johns Hopkins University Compositions and methods for chemical exchange saturation transfer (cest) based magnetic resonance imaging (mri)
CN104693063A (zh) * 2015-03-18 2015-06-10 中国药科大学制药有限公司 一种曲尼司特的合成方法
US11014873B2 (en) 2017-02-03 2021-05-25 Certa Therapeutics Pty Ltd. Anti-fibrotic compounds
CN110357789B (zh) * 2018-04-11 2022-09-30 华东理工大学 作为dhodh抑制剂的n-取代丙烯酰胺衍生物及其制备和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3043868A (en) * 1959-12-09 1962-07-10 Searle & Co N-xenylalkanoylaminoalkanoic acids and esters thereof
GB1074480A (en) * 1964-07-29 1967-07-05 Pfizer & Co C Amino acid derivatives and method of preparation
AT313463B (de) * 1968-05-18 1974-02-25 Rhodiaceta Ag Verfahren und Vorrichtung zur Herstellung eines Wirrfadens

Also Published As

Publication number Publication date
GB1446141A (en) 1976-08-18
DK139676C (da) 1979-09-10
NL7400754A (es) 1974-07-22
IT1054151B (it) 1981-11-10
JPS4993335A (es) 1974-09-05
FI60555B (fi) 1981-10-30
JPS5640710B2 (es) 1981-09-22
NO142441B (no) 1980-05-12
USRE32944E (en) 1989-06-06
NO740137L (no) 1974-07-19
FI60555C (fi) 1982-02-10
FR2214476A1 (es) 1974-08-19
AU6461374A (en) 1975-07-17
US3940422A (en) 1976-02-24
NL179370B (nl) 1986-04-01
BG24538A3 (en) 1978-03-10
BE809935A (fr) 1974-05-16
DK139676B (da) 1979-03-26
CH615152A5 (en) 1980-01-15
NL179370C (nl) 1986-09-01
CH613442A5 (es) 1979-09-28
ES422395A1 (es) 1976-08-01
DE2402398A1 (de) 1974-08-08
AT333726B (de) 1976-12-10
ATA44374A (de) 1976-04-15
FR2214476B1 (es) 1977-08-12
HU168055B (es) 1976-02-28
SE411117B (sv) 1979-12-03
DE2402398B2 (de) 1980-10-09
DE2402398C3 (de) 1981-07-23
SU520041A3 (ru) 1976-06-30

Similar Documents

Publication Publication Date Title
NO142441C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme karboksylsyrederivater
NO146200C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 16-oksygenerte prostansyrederivater
NO145576C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive penicillinderivater
NO141407C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive etylenderivater
NO142258C (no) Fremgangsmaate for fremstilling av alfa-aryl-propionsyrer
SE398229B (sv) Forfarande for framstellning av 4-fenoxi-fenoxialkankarbonsyraderivat
NO149281C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater
SE7908625L (sv) Acetylglykosylmykofenolsyraforeningar for framstellning av glykosylmykofenolsyraforeningar
SE419538B (sv) Analogiforfaranden for framstellning av 2-(n-fenoxfenyl)-propionsyraderivat
NO142303C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme oksazolderivater
NO147917C (no) Fremgangsmaate for fremstilling av 3-metyl-delta3-cefem-4-karboksylsyre-forbindelser
NO741125A (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive pyrido-pyrimidin-derivater.
NO141755C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme dotriacontapeptidamider
NO142260C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater
NO791267L (no) Fremgangsmaate ved fremstilling av 5-fluor-2-methyl-indanol-3-eddiksyreforbindelser
SE419646B (sv) Forfarande for framstellning av 8-halogen-dibensofuran-3-ettiksyra-derivat
NO138561C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme cykloalkylfenoksykarboksylsyrederivater
NO144110C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5:6-benzo-4-pyron-derivater
NO147754C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme cefemderivater.
NO142307C (no) Fremgangsmaate ved fremstilling av pregnansyrederivater
SE7601151L (sv) Forfarande for framstellning av cefemkarboxylsyror
NO139890C (no) Fremgangsmaate ved fremstilling av n5 -methyltetrahydrohomofolinsyre
NO142909C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-benzazoninderivater
NO139961C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive benzopyranopyridinderivater
NO141758C (no) Analogifremgangsmaate til fremstilling av anthelmintisk virksomme 5-fenylsulfinyl-2-benzimidazolkarbaminsyreestere